Neuroendocrine tumors and rare gastrointestinal malignancies represent a diverse and complex group of diseases with variable clinical behavior. Improved awareness, advanced imaging, and biomarker development have led to increased detection. Accurate classification and staging are essential for appropriate management. Treatment often requires individualized strategies involving surgery, endoscopic therapy, systemic treatment, and targeted approaches. Long-term surveillance is critical due to the risk of recurrence and progression. This topic addresses diagnostic challenges, evolving therapeutic options, and multidisciplinary management of rare GI cancers.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China